|
End-of-day quote
LUXEMBOURG S.E.
2026-10-02
|
5-day change | 1st Jan Change | ||
| 38.00 USD | 0.00% |
|
-2.56% | +25.83% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
| Market Cap | 2,231B 6.82B 6.06B 5.66B 5.16B 9.72B 656B 9.81B 68.46B 26.53B 335B 25.61B 25.06B 1,076B | P/E 2026 * |
9x | P/E 2027 * | 7.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1,968B 6.02B 5.35B 4.99B 4.55B 8.58B 579B 8.66B 60.4B 23.41B 296B 22.6B 22.11B 949B | EV / Sales 2026 * |
2.07x | EV / Sales 2027 * | 1.78x |
| Free-Float |
72.87% | Yield 2026 * |
4.94% | Yield 2027 * | 5.54% |
Last Transcript: Gedeon Richter
| 1 week | -2.56% | ||
| Current month | -2.56% | ||
| 1 month | -5.94% | ||
| 3 months | -3.55% | ||
| 6 months | +4.40% | ||
| Current year | +25.83% |
| 1 week | 38 | 39 | |
| 1 month | 38 | 40.8 | |
| Current year | 30 | 43.2 | |
| 1 year | 28.8 | 43.2 | |
| 3 years | 23.4 | 43.2 | |
| 5 years | 16.5 | 43.2 | |
| 10 years | 15.6 | 43.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gábor Orbán
CEO | Chief Executive Officer | 47 | 2017-10-31 |
| Director of Finance/CFO | - | 2025-04-30 | |
Attila Szénási
COO | Chief Operating Officer | - | 2018-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Erik Bogsch
CHM | Chairman | 79 | 2016-12-31 |
Szilveszter Vizi
CHM | Chairman | 90 | 2024-02-29 |
| Director/Board Member | 65 | 2012-04-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -2.56% | - | - | 6.9B | ||
| -0.61% | -3.43% | +39.40% | +112.31% | 1,025B | ||
| -1.02% | -5.60% | +37.67% | +65.02% | 623B | ||
| +1.11% | -0.58% | +11.10% | +77.28% | 459B | ||
| +0.34% | -3.01% | +61.21% | +40.71% | 355B | ||
| -0.95% | -4.05% | +21.60% | +39.37% | 336B | ||
| -1.46% | -2.89% | +11.84% | +24.60% | 270B | ||
| -1.35% | -5.43% | -4.69% | +8.40% | 247B | ||
| -1.04% | -2.79% | +35.52% | +51.34% | 220B | ||
| -1.87% | -4.10% | +30.92% | +95.33% | 183B | ||
| Average | -0.21% | -3.15% | +27.17% | +57.15% | 413.14B | |
| Weighted average by Cap. | +0.42% | -3.17% | +30.51% | +68.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 951B 2.91B 2.58B 2.41B 2.2B 4.15B 280B 4.19B 29.2B 11.31B 143B 10.92B 10.69B 459B | 1,021B 3.12B 2.77B 2.59B 2.36B 4.45B 300B 4.49B 31.33B 12.14B 153B 11.72B 11.47B 492B |
| Net income | 254B 778M 691M 645M 588M 1.11B 74.76B 1.12B 7.8B 3.02B 38.22B 2.92B 2.86B 123B | 291B 889M 789M 737M 672M 1.27B 85.42B 1.28B 8.92B 3.46B 43.67B 3.34B 3.26B 140B |
| Net Debt | -262B -803M -713M -666M -607M -1.14B -77.16B -1.15B -8.06B -3.12B -39.45B -3.01B -2.95B -127B | -410B -1.25B -1.11B -1.04B -948M -1.79B -121B -1.8B -12.58B -4.88B -61.62B -4.71B -4.61B -198B |
| Date | Price | Change |
|---|---|---|
| 26-10-02 | US$38.00 | 0.00% |
| 26-10-01 | US$38.00 | -2.56% |
| 26-09-30 | US$39.00 | +2.63% |
| 26-09-29 | US$38.00 | -0.52% |
| 26-09-28 | US$38.20 | -2.05% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RICHTER Stock
- CHWGR Stock
Select your edition
All financial news and data tailored to specific country editions
















